Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases—A Possible Association with High Rheumatoid Arthritis Disease Activity

SIMPLE SUMMARY: Immunotherapy blocking programmed cell death protein 1 (PD-1) and its ligands (PD-L1, PD-L2) is less effective in non-Hodgkin lymphoma (NHL) than classical Hodgkin lymphoma. However, NHL is a heterogeneous group and current research seeks to identify subgroups of NHL patients respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellbacher, Erik, Sundström, Christer, Molin, Daniel, Baecklund, Eva, Hollander, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946311/
https://www.ncbi.nlm.nih.gov/pubmed/35326658
http://dx.doi.org/10.3390/cancers14061509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946311/
https://www.ncbi.nlm.nih.gov/pubmed/35326658
http://dx.doi.org/10.3390/cancers14061509

Ejemplares similares